4 insiders at Larimar Therapeutics, Inc. (LRMR) reported open-market stock purchases totaling $25,716,890 in recent weeks, according to filings with the U.S. Securities and Exchange Commission. The largest reported purchase came from Flynn James E (director, 10 percent owner, other: * Director by Deputization), who acquired 2,000,000 shares at $5.00 on February 27, 2026.
Source: SEC Form 4. Option grants and tax-withholding sales are excluded.
| Date | Insider | Role | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|
| 2026-07-06 | Hamilton Thomas Edward | director | 50,000 | $3.34 | $166,890 | SEC Form 4 |
| 2026-02-27 | Flynn James E | director, 10 percent owner, other: * Director by Deputization | 1,084,012 | $5.00 | $5,420,060 | SEC Form 4 |
| 2026-02-27 | Flynn James E | director, 10 percent owner, other: * Director by Deputization | 1,084,010 | $5.00 | $5,420,050 | SEC Form 4 |
| 2026-02-27 | Flynn James E | director, 10 percent owner, other: * Director by Deputization | 831,978 | $5.00 | $4,159,890 | SEC Form 4 |
| 2026-02-27 | Flynn James E | director, 10 percent owner, other: * Director by Deputization | 2,000,000 | $5.00 | $10,000,000 | SEC Form 4 |
| 2026-02-27 | Hamilton Thomas Edward | director | 100,000 | $5.00 | $500,000 | SEC Form 4 |
| 2026-02-27 | THOMAS FRANK E | director | 5,000 | $5.00 | $25,000 | SEC Form 4 |
| 2026-02-27 | SHERMAN JEFFREY W | director | 5,000 | $5.00 | $25,000 | SEC Form 4 |
Larimar Therapeutics, Inc. is a Healthcare company in the Biotechnology industry. It carried a market capitalization of about $309M, with shares trading near $3.61.
This article is automated factual reporting of public SEC filings, for informational purposes only. It is not investment advice, nor a recommendation, offer or solicitation to buy or sell any security, and reflects no opinion on the company. Figures are drawn from filings believed reliable but are not guaranteed. Always verify against the primary SEC filing and consult a licensed professional. Investing can lose value, up to total loss.